Sodium Thiosulfate Patent Expiration
Sodium Thiosulfate is Used for reducing ototoxicity in pediatric patients with localized medulloblastoma following cisplatin administration. It was first introduced by United States Army Office Surgeon General
Sodium Thiosulfate Patents
Given below is the list of patents protecting Sodium Thiosulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pedmark | US11291728 | Anhydrous sodium thiosulfate and formulations thereof | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11510984 | Anhydrous sodium thiosulfate and formulations thereof | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11617793 | Anhydrous sodium thiosulfate and formulations thereof | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11964018 | Therapeutic uses for sodium thiosulfate formulations | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11992530 | Therapeutic uses for sodium thiosulfate and formulations | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11998604 | Therapeutic uses for sodium thiosulfate formulations | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US10596190 | Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy | Jan 05, 2038 | Fennec Pharms Inc |
| Sodium Thiosulfate | US8496973 | Sodium thiosulfate-containing pharmaceutical compositions | Mar 29, 2031 | Hope Pharms |
| Sodium Thiosulfate | US10479686 | Sodium thiosulfate-containing pharmaceutical compositions | Jul 07, 2030 | Hope Pharms |
| Sodium Thiosulfate | US9345724 | Sodium thiosulfate-containing pharmaceutical compositions | Jul 07, 2030 | Hope Pharms |
| Sodium Thiosulfate | US9585912 | Sodium thiosulfate-containing pharmaceutical compositions | Jul 07, 2030 | Hope Pharms |
| Sodium Thiosulfate | US11753301 | Sodium thiosulfate-containing pharmaceutical compositions | Feb 10, 2030 | Hope Pharms |
| Sodium Thiosulfate | US12304813 | Sodium thiosulfate-containing pharmaceutical compositions | Feb 10, 2030 | Hope Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Sodium Thiosulfate's patents.
Latest Legal Activities on Sodium Thiosulfate's Patents
Given below is the list recent legal activities going on the following patents of Sodium Thiosulfate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 27 May, 2025 | US12304813 |
| Patent eGrant Notification | 20 May, 2025 | US12304813 |
| Mail Patent eGrant Notification | 20 May, 2025 | US12304813 |
| Recordation of Patent eGrant | 20 May, 2025 | US12304813 |
| Email Notification | 20 May, 2025 | US12304813 |
| Patent Issue Date Used in PTA Calculation | 20 May, 2025 | US12304813 |
| Email Notification | 08 May, 2025 | US12304813 |
| Issue Notification Mailed | 07 May, 2025 | US12304813 |
| Application Is Considered Ready for Issue | 22 Apr, 2025 | US12304813 |
| Dispatch to FDC | 22 Apr, 2025 | US12304813 |
Sodium Thiosulfate's Family Patents
